Pharmaceutical & API manufacturing sites in Norway
8 drug establishments in Norway are registered with the US FDA; 5 (63%) list API manufacture among their operations. 5 registrant companies are identified; sites whose registrant is not resolved to a company profile are not counted. 3 published sites are matched to an EU or UK GMP certificate inspected within the last three years.
Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology
- FDA-registered sites
- 8
- Registered for API manufacture
- 5
- Identified registrants
- 5
- Current EU/UK GMP match
- 3
Registered operations
| API manufacture | 5 |
| Drug manufacture | 5 |
| Analytical testing | 4 |
| Packaging | 4 |
| Labelling | 2 |
A site can register several operations, so these do not add up to the site total.
Companies headquartered in NorwayAPI manufacturing sites (5)
- GE Healthcare ASOsloGMP match
- Borregaard ASSarpsborgGMP match
- BASF AS avd SandefjordSandefjord
- GE Healthcare AS avd LindesnesLindesnes
- Vistin Pharma AS avd Krager� FikkjebakkeSannidal
Other sites with EU/UK GMP documents (2)
Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.